MX384745B - Proceso para la preparación de compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidina-2,7-diona 3-sustituidos. - Google Patents
Proceso para la preparación de compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidina-2,7-diona 3-sustituidos.Info
- Publication number
- MX384745B MX384745B MX2019008116A MX2019008116A MX384745B MX 384745 B MX384745 B MX 384745B MX 2019008116 A MX2019008116 A MX 2019008116A MX 2019008116 A MX2019008116 A MX 2019008116A MX 384745 B MX384745 B MX 384745B
- Authority
- MX
- Mexico
- Prior art keywords
- thiazolo
- pyrimidine
- amino
- substituted
- sup
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La presente invención se refiere a un proceso para sintetizar un compuesto de fórmula (I), (I),(ver formula) R1 es H o alquilo C1-6; R2 es H o hidroxi; o una sal o diastereómero farmacéuticamente aceptable, que es útil para la profilaxis y el tratamiento de una enfermedad viral en un paciente relacionada con infección por hepatitis B o una enfermedad causada por infección por hepatitis B.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2017070437 | 2017-01-06 | ||
| CN2017112149 | 2017-11-21 | ||
| PCT/EP2018/050159 WO2018127525A1 (en) | 2017-01-06 | 2018-01-04 | PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-d]PYRIMIDINE-2,7-DIONE COMPOUNDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019008116A MX2019008116A (es) | 2019-09-04 |
| MX384745B true MX384745B (es) | 2025-03-14 |
Family
ID=60953862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019008116A MX384745B (es) | 2017-01-06 | 2018-01-04 | Proceso para la preparación de compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidina-2,7-diona 3-sustituidos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11142534B2 (es) |
| EP (1) | EP3568400B1 (es) |
| JP (2) | JP7201598B2 (es) |
| KR (1) | KR102602328B1 (es) |
| CN (1) | CN110139868B (es) |
| AU (2) | AU2018205994B2 (es) |
| CA (1) | CA3048768A1 (es) |
| IL (1) | IL267801B2 (es) |
| MX (1) | MX384745B (es) |
| TW (1) | TWI808068B (es) |
| WO (1) | WO2018127525A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL307295A (en) * | 2017-01-06 | 2023-11-01 | Hoffmann La Roche | Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[5,4-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran -2-yl]propyl]acetate |
| WO2018127525A1 (en) * | 2017-01-06 | 2018-07-12 | F. Hoffmann-La Roche Ag | PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-d]PYRIMIDINE-2,7-DIONE COMPOUNDS |
| US12012421B2 (en) | 2017-07-07 | 2024-06-18 | Hoffmann-La Roche Inc. | Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate |
| US12012420B2 (en) | 2017-11-21 | 2024-06-18 | Hoffmann-La Roche, Inc. | Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate |
| WO2025032082A1 (en) | 2023-08-08 | 2025-02-13 | F. Hoffmann-La Roche Ag | Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5476659A (en) | 1982-11-09 | 1995-12-19 | The Scripps Research Institute | Cancerous B cell treatment using substituted nucleoside derivatives |
| US5166141A (en) | 1983-11-01 | 1992-11-24 | Scripps Clinic And Research Foundation | Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals |
| US5041426A (en) | 1987-12-21 | 1991-08-20 | Brigham Young University | Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
| FR2668153B1 (fr) * | 1990-10-22 | 1995-03-31 | Pasteur Merieux Serums Vacc | Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant. |
| AU727177B2 (en) | 1996-10-16 | 2000-12-07 | Icn Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses thereof |
| EP1072607A3 (en) | 1996-10-16 | 2001-09-12 | ICN Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses therof |
| WO2005016235A2 (en) | 2003-04-14 | 2005-02-24 | The Regents Of The University Of California | Combined use of impdh inhibitors with toll-like receptor agonists |
| EP1667694B1 (en) | 2003-09-05 | 2010-04-28 | Anadys Pharmaceuticals, Inc. | Tlr7 ligands for the treatment of hepatitis c |
| ES2459368T3 (es) * | 2004-12-17 | 2014-05-09 | Anadys Pharmaceuticals, Inc. | Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos |
| CA2630463C (en) | 2005-11-21 | 2015-01-06 | Anadys Pharmaceuticals, Inc. | Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2-one |
| CL2007001427A1 (es) | 2006-05-22 | 2008-05-16 | Novartis Ag | Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po |
| CA2655904C (en) | 2006-06-22 | 2014-11-18 | Anadys Pharmaceuticals, Inc. | Prodrugs of 5-amino-3-(3'-deoxy-.beta.-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione |
| EP2040712B1 (en) | 2006-07-18 | 2011-03-02 | Anadys Pharmaceuticals, Inc. | Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| BRPI0717741A2 (pt) * | 2006-10-17 | 2014-04-08 | Anadys Pharmaceuticals Inc | Compostos e respectivos método de preparação, método de redução de composto de sulfonil substituído, composição farmacêutica método de tratamento ou prevenção de doença |
| WO2009026292A1 (en) | 2007-08-20 | 2009-02-26 | Anadys Pharmaceuticals, Inc. | Dosing methods for treating disease |
| HUE053704T2 (hu) | 2014-12-08 | 2021-07-28 | Hoffmann La Roche | 3-szubsztitutált 5-amino-6H-tiazolo[4,5-d]pirimidin-2,7-dion vegyületek vírusfertõzések kezelésére és megelõzésére |
| CN107427514B (zh) | 2015-03-16 | 2021-07-13 | 豪夫迈·罗氏有限公司 | 使用tlr7激动剂和hbv衣壳装配抑制剂的组合治疗 |
| CN107592864B (zh) | 2015-05-12 | 2021-04-16 | 豪夫迈·罗氏有限公司 | 用于治疗和预防病毒感染的新的取代的氨基噻唑并嘧啶二酮 |
| CN107820498B (zh) | 2015-06-30 | 2020-06-19 | 豪夫迈·罗氏有限公司 | 用于治疗和预防病毒感染的取代的氨基噻唑并嘧啶二酮 |
| WO2018127525A1 (en) * | 2017-01-06 | 2018-07-12 | F. Hoffmann-La Roche Ag | PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-d]PYRIMIDINE-2,7-DIONE COMPOUNDS |
-
2018
- 2018-01-04 WO PCT/EP2018/050159 patent/WO2018127525A1/en not_active Ceased
- 2018-01-04 JP JP2019536123A patent/JP7201598B2/ja active Active
- 2018-01-04 CN CN201880005928.5A patent/CN110139868B/zh active Active
- 2018-01-04 CA CA3048768A patent/CA3048768A1/en active Pending
- 2018-01-04 KR KR1020197021399A patent/KR102602328B1/ko active Active
- 2018-01-04 US US16/476,165 patent/US11142534B2/en active Active
- 2018-01-04 EP EP18700181.3A patent/EP3568400B1/en active Active
- 2018-01-04 MX MX2019008116A patent/MX384745B/es unknown
- 2018-01-04 AU AU2018205994A patent/AU2018205994B2/en not_active Ceased
- 2018-01-05 TW TW107100418A patent/TWI808068B/zh active
-
2019
- 2019-07-02 IL IL267801A patent/IL267801B2/en unknown
-
2021
- 2021-10-29 AU AU2021258083A patent/AU2021258083A1/en not_active Abandoned
-
2022
- 2022-10-21 JP JP2022168922A patent/JP2023011699A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200024287A1 (en) | 2020-01-23 |
| IL267801A (en) | 2019-09-26 |
| WO2018127525A1 (en) | 2018-07-12 |
| TWI808068B (zh) | 2023-07-11 |
| JP2023011699A (ja) | 2023-01-24 |
| AU2021258083A1 (en) | 2021-11-25 |
| MX2019008116A (es) | 2019-09-04 |
| TW201829419A (zh) | 2018-08-16 |
| JP7201598B2 (ja) | 2023-01-10 |
| KR102602328B1 (ko) | 2023-11-16 |
| CN110139868A (zh) | 2019-08-16 |
| US11142534B2 (en) | 2021-10-12 |
| EP3568400C0 (en) | 2025-11-19 |
| KR20190099492A (ko) | 2019-08-27 |
| EP3568400A1 (en) | 2019-11-20 |
| EP3568400B1 (en) | 2025-11-19 |
| AU2018205994A1 (en) | 2019-06-13 |
| CN110139868B (zh) | 2021-07-09 |
| IL267801B2 (en) | 2023-07-01 |
| JP2020504126A (ja) | 2020-02-06 |
| BR112019013884A2 (pt) | 2020-03-03 |
| IL267801B1 (en) | 2023-03-01 |
| CA3048768A1 (en) | 2018-07-12 |
| AU2018205994B2 (en) | 2021-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX380516B (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico | |
| JOP20210001A1 (ar) | مشتقات 3-(5- هيدروكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخدامها لمعالجة أمراض مرتبطة ببروتين ذات أصبع الزنك من عائلة (ikaros 2 (ikzf2 | |
| GEAP202315746A (en) | Protein tyrosine phosphatase inhibitors | |
| MX2022015703A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados a braf. | |
| MX2010007375A (es) | Nuevos derivados de lupano. | |
| EA201992601A1 (ru) | Конденсированное имидазопиперидиновое соединение, являющееся ингибитором jak | |
| MX2020008816A (es) | Derivados de triazina para el tratamiento de enfermedades relacionadas con neurotrofinas. | |
| MA41338A (fr) | Composés de pyrazine pour le traitement de maladies infectieuses | |
| PH12017501061A1 (en) | 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection | |
| MX2010007374A (es) | Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. | |
| MX2009008338A (es) | Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio. | |
| MX2021006902A (es) | Nuevos compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica. | |
| MY155255A (en) | Spiro-oxindole compounds and their use as therapeutic agents | |
| MX2009003874A (es) | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. | |
| WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
| PH12015501560A1 (en) | Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
| MX2020012827A (es) | Compuestos tetrahidro-1h-pirazino[2,1-a]isoindolilquinolina para el tratamiento de enfermedades autoinmunes. | |
| MX2021012223A (es) | Compuestos de hexahidro-1h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria. | |
| PH12021552513A1 (en) | Pyrrole compounds | |
| NZ758449A (en) | Heteroaromatic compounds useful in therapy | |
| UY27577A1 (es) | Inhibidores de la integrasa del vih | |
| MX2019008116A (es) | Proceso para la preparacion de compuestos de 5-amino-6h-tiazolo[4, 5-d]pirimidina-2,7-diona 3-sustituidos. | |
| MX2025010256A (es) | Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| PH12018502012A1 (en) | Griseofulvin compound |